ScholarGate
Msaidizi
Process / pipelineClinical / epidemiology

Jaribio la Kimatibabu la Awamu ya II Lililolinganishwa

Jaribio la kimatibabu la Awamu ya II lililolinganishwa ni utafiti wa ufanisi wa mapema wa mkono mmoja au unaodhibitiwa kidogo ambapo wagonjwa wanaotibiwa huunganishwa na udhibiti uliolinganishwa — unaotokana na hifadhidata za kihistoria, rejista, au vikundi vya nje vinavyofanana — kwa vigezo muhimu vya utabiri kama vile umri, hatua ya ugonjwa, na hali ya utendaji. Muundo huu huruhusu tathmini ya awali ya ufanisi bila mkono wa nasibu unaofanana, ukibadilisha unasihi kwa uwezekano huku ukidhibiti kwa kiasi kikubwa usumbufu kupitia mchakato wa kulinganisha.

Fungua katika MethodMindHivi karibuniApply, compare, get guidance
Tools & resources
Pakua slaidi
Learn & explore
VideoHivi karibuni

Soma mbinu kamili

Kwa wanachama pekee

Ingia kwa akaunti ya bure ili kusoma sehemu hii.

Ingia

Ramani ya mbinu

Jirani ya mbinu zinazohusiana — chagua nodi ili kuchunguza.

Vyanzo

  1. Gehan, E. A. (1961). The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. Journal of Chronic Diseases, 13(4), 346–353. DOI: 10.1016/0021-9681(61)90060-1
  2. Simon, R. (1989). Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials, 10(1), 1–10. DOI: 10.1016/0197-2456(89)90015-9

Jinsi ya kunukuu ukurasa huu

ScholarGate. (2026, June 3). Matched Phase II Clinical Trial. ScholarGate. https://scholargate.app/sw/epidemiology/matched-phase-ii-clinical-trial

Mbinu ipi?

Weka mbinu hii kando ya jamaa zake wa karibu na uzisome bega kwa bega — maktaba huweka vitabu mezani; uamuzi ni wako.

Linganisha bega kwa bega
ScholarGateMatched Phase II clinical trial (Matched Phase II Clinical Trial). Imepatikana 2026-06-18 kutoka https://scholargate.app/sw/epidemiology/matched-phase-ii-clinical-trial · Seti ya data: https://doi.org/10.5281/zenodo.20539026